enGene Holdings Inc. Annual Operating Income (Loss) in USD from 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
enGene Holdings Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2022 to 2023.
  • enGene Holdings Inc. Operating Income (Loss) for the quarter ending July 31, 2024 was -$16.8M, a 168% decline year-over-year.
  • enGene Holdings Inc. Operating Income (Loss) for the twelve months ending July 31, 2024 was -$55.3M.
  • enGene Holdings Inc. annual Operating Income (Loss) for 2023 was -$26.1M, a 34.1% decline from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$26.1M -$6.63M -34.1% Nov 1, 2022 Oct 31, 2023 10-K 2024-01-29
2022 -$19.4M Nov 1, 2021 Oct 31, 2022 10-K 2024-01-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.